|Slideshows|August 20, 2021

In the Wake of 9/11: Mental Health Statistics of First Responders

What toll does trauma take on police officers, firefighters, and EMT workers?

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe

Related Content

ALTO-203, an H3 Inverse Agonist, in Depression: Biomarker and Pharmacodynamic Findings

ByAmit Etkin, MD, PhD

June 9th 2026

Predicting Relapse in Treatment-Resistant Depression: Findings From New Esketamine Analysis

ByLeighann Forbes, PhD

June 8th 2026

Suicide Risk Assessment in Patients Denying Suicidal Intent

ByIgor Galynker, MD, PhD,Jessica Walters

June 4th 2026

FDA Grants De Novo Approval to Modius Spero, Neuromodulation Device for PTSD

ByLeah Kuntz

May 26th 2026

Narrative Crisis Model: A Suggested Redefinition of the Clinical Understanding of Suicidal Mental Process

ByJayashree Balasubramanian, MA, MS,Rawad El Hayek, MD,Igor Galynker, MD, PhD

May 20th 2026

Latest CME

In-Person Event

Southern California Psychiatry Conference

July 10-11, 2026

Register now!

Video

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

In the Wake of 9/11: Mental Health Statistics of First Responders

Related Content

ALTO-203, an H3 Inverse Agonist, in Depression: Biomarker and Pharmacodynamic Findings

Predicting Relapse in Treatment-Resistant Depression: Findings From New Esketamine Analysis

Suicide Risk Assessment in Patients Denying Suicidal Intent

FDA Grants De Novo Approval to Modius Spero, Neuromodulation Device for PTSD

Narrative Crisis Model: A Suggested Redefinition of the Clinical Understanding of Suicidal Mental Process

Latest CME

Southern California Psychiatry Conference

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Trending on Psychiatric Times

“Engineered Addiction”: Redefining Addictive Disorders and the Psychiatric Impact of Social Media

Paying Attention to the Psychopharmacology Pipeline

Podcast: Early Intervention & Psychopharmacology in Bipolar Disorder With Robert M. Post, MD

ALTO-203, an H3 Inverse Agonist, in Depression: Biomarker and Pharmacodynamic Findings

Predicting Relapse in Treatment-Resistant Depression: Findings From New Esketamine Analysis